197711-04-9

Basic information

• Product Name: 2-(3-broMo-2,6-diMethylphenyl)acetic acid
• Synonyms: 2-(3-broMo-2,6-diMethylphenyl)acetic acid;Benzeneacetic acid, 3-broMo-2,6-diMethyl-
• CAS NO: 197711-04-9
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.09714
• Mol File: 197711-04-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(3-broMo-2,6-diMethylphenyl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-broMo-2,6-diMethylphenyl)acetic acid(197711-04-9)
• EPA Substance Registry System: 2-(3-broMo-2,6-diMethylphenyl)acetic acid(197711-04-9)

Safety Data

• Hazardous Substances Data: 197711-04-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-(3-bromo-2,6-dimethylphenyl)acetic acid is used as a building block in organic synthesis for the production of pharmaceuticals. Its unique structure and functional groups make it a valuable component in the development of new drugs, particularly those targeting inflammation and other conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(3-bromo-2,6-dimethylphenyl)acetic acid is utilized as a key intermediate in the synthesis of various agrochemicals. Its properties contribute to the creation of effective compounds for crop protection and enhancement of agricultural productivity.
Used as a Drug Intermediate:
2-(3-bromo-2,6-dimethylphenyl)acetic acid is employed as a drug intermediate, playing a crucial role in the synthesis of medicinal compounds. Its presence in the molecular structure can influence the pharmacological properties of the final drug, making it an essential component in drug development processes.
Used for Anti-inflammatory Research:
This chemical has been studied for its anti-inflammatory properties, making it a potential candidate for the development of anti-inflammatory drugs. Its ability to modulate inflammatory responses could lead to the creation of new therapeutic agents for treating various inflammatory conditions.

Upstream product

• 98-19-1 5-tert-Butyl-m-xylene 
• 1260490-37-6 4-tert-butyl-2,6-dimethylmandelic acid 
• 854646-92-7 (4-tert-butyl-2,6-dimethyl-phenyl)-acetic acid 
• 938-50-1 2-(2,6-dimethylphenyl)acetic acid 

Downstream Products

• 1329580-40-6 3-(3-bromo-2,6-dimethylphenyl)-4-hydroxy-1-azaspiro[4.5]dec-3-ene-2,8-dione 
• 1329580-38-2 11-(3-bromo-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one 
• 1329580-36-0 methyl 8-{[(3-bromo-2,6-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 1329581-37-4 (3-bromo-2,6-dimethylphenyl)acetyl chloride 
• 1326777-95-0 C₁₉H₂₇BrN₂O₄ 

Relevant articles and documents

ROR NUCLEAR RECEPTOR MODULATORS

The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.

Method for Producing (2,4-Dimethylbiphenyl-3-yl)Acetic Acids, the Esters Thereof and Intermediate Compounds

The present invention relates to a novel process for preparing substituted and unsubstituted (2,4-dimethylbiphenyl-3-yl)acetic acids and their esters of the formula (I) using homogeneous and heterogeneous palladium catalysts, and also the intermediates 4-tert-butyl-2,6-dimethylphenylacetic acid and 4-tert-butyl-2,6-dimethylmandelic acid, and to processes for their preparation.